EphB 2 as a Therapeutic Antibody Drug Target for the Treatment of Colorectal Cancer

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Development of potent monoclonal antibody auristatin conjugates for cancer therapy

  2003cited by this paper
• Human osteosarcoma expresses specific ephrin profiles

  2002cited by this paper
• Ephrins in reverse, park and drive.

  2002cited by this paper
• Ephrin-As as receptors in topographic projections.

  2002cited by this paper
• Catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression

  2002cited by this paper
• The role of the Eph-ephrin signalling system in the regulation of developmental patterning.

  2002cited by this paper
• Mechanisms and functions of eph and ephrin signalling

  2002cited by this paper
• Designing immunotoxins for cancer therapy

  2002cited by this paper
• The ephrins and Eph receptors in angiogenesis.

  2002cited by this paper
• EphB ligand, ephrinB2, suppresses the VEGF‐ and angiopoietin‐1‐induced Ras/mitogen‐activated protein kinase pathway in venous endothelial cells

  2002cited by this paper
• Diverse roles for the Eph family of receptor tyrosine kinases in carcinogenesis

  2002cited by this paper
• Coexpression of ephrin‐Bs and their receptors in colon carcinoma

  2002cited by this paper
• Multiple roles of eph receptors and ephrins in neural development

  2001cited by this paper
• Downregulation of the Ras–Mitogen-Activated Protein Kinase Pathway by the EphB2 Receptor Tyrosine Kinase Is Required for Ephrin-Induced Neurite Retraction

  2001cited by this paper
• Improving the efficacy of antibody-based cancer therapies

  2001cited by this paper
• Receptor protein tyrosine kinase EphB4 is up-regulated in colon cancer

  2001cited by this paper
• EphA receptors regulate growth cone dynamics through the novel guanine nucleotide exchange factor ephexin.

  2001cited by this paper
• Association among EPHB2, TrkA, and MYCN expression in low-stage neuroblastomas.

  2001cited by this paper
• Toxin-labeled monoclonal antibodies.

  2001cited by this paper
• Multiple signaling interactions of Abl and Arg kinases with the EphB2 receptor

  2001cited by this paper
• Expression of receptor tyrosine kinase EphB4 and its ligand ephrin-B2 is associated with malignant potential in endometrial cancer.

  2001cited by this paper
• Eph receptors and ephrin ligands. essential mediators of vascular development.

  2000cited by this paper
• Protein tyrosine kinases in malignant melanoma.

  2000cited by this paper
• Eph receptors and ephrins: regulators of guidance and assembly.

  2000cited by this paper
• Mechanisms of action and resistance to tubulin-binding agents

  2000cited by this paper
• Eph receptors and ephrins.

  2000cited by this paper
• The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization

  2000cited by this paper
• Eph receptors and ephrin ligands: embryogenesis to tumorigenesis

  2000cited by this paper
• Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets

  2000cited by this paper
• Eph receptors and ephrins: effectors of morphogenesis.

  1999cited by this paper
• Coexpression of transcripts encoding EPHB receptor protein tyrosine kinases and their ephrin-B ligands in human small cell lung carcinoma.

  1999cited by this paper
• Bidirectional signals establish boundaries.

  1999cited by this paper
• Monoclonal antibody therapy of cancer

  1999cited by this paper
• Ephrins and their Eph receptors: multitalented directors of embryonic development

  1999cited by this paper
• High-level expression of EPHB6, EFNB2, and EFNB3 is associated with low tumor stage and high TrkA expression in human neuroblastomas.

  1999cited by this paper
• Complex formation between EphB2 and Src requires phosphorylation of tyrosine 611 in the EphB2 juxtamembrane region

  1998cited by this paper
• Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas.

  1998cited by this paper
• The ephrins and Eph receptors in neural development.

  1998cited by this paper
• Juxtamembrane tyrosine residues couple the Eph family receptor EphB2/Nuk to specific SH2 domain proteins in neuronal cells

  1997cited by this paper
• Ligand Activation of ELK Receptor Tyrosine Kinase Promotes Its Association with Grb10 and Grb2 in Vascular Endothelial Cells*

  1996cited by this paper
• Antineoplastic agents 337. Synthesis of dolastatin 10 structural modifications.

  1995cited by this paper
• Activation of the Eck receptor protein tyrosine kinase stimulates phosphatidylinositol 3-kinase activity.

  1994cited by this paper
• Ligands for EPH-related receptor tyrosine kinases that require membrane attachment or clustering for activity.

  1994cited by this paper
• Rapid constitutive internalization and externalization of epidermal growth factor receptors in isolated rat hepatocytes. Monensin inhibits receptor externalization and reduces the capacity for continued endocytosis of epidermal growth factor.

  1988cited by this paper

• Eph Receptors in Cancer

  2023cites this paper
• Hepatocytes demarcated by EphB2 contribute to the progression of nonalcoholic steatohepatitis

  2023cites this paper
• The Role of Ephs and Ephrins in Memory Formation

  2015cites this paper
• Monoclonal antibodies for targeted therapy in colorectal cancer.

  2010cites this paper
• Eph, a Protein Family Coming of Age: More Confusion, Insight, or Complexity?

  2008cites this paper
• Potent AntitumorActivity of an Auristatin-Conjugated , Fully Human Monoclonal Antibody to Prostate-SpecificMembrane Antigen

  2006cites this paper
• Caveolin-1 is required for signaling and membrane targeting of EphB1 receptor tyrosine kinase

  2006cites this paper
• Recombinant Chimeric Antibody hCAb as a Novel Anti-human Colorectal Carcinoma Agent

  2006cites this paper
• EphB2 Expression across 138 Human Tumor Types in a Tissue Microarray: High Levels of Expression in Gastrointestinal Cancers

  2005cites this paper
• Identification and validation of cell surface antigens for antibody targeting in oncology.

  2004influential citation